Loss of STING expression is prognostic in non-small cell lung cancer.
Zoltan LohinaiDavid DoraCharles CaldwellChristopher J RivardKenichi SudaHui YuGareth RivallandKim EllisonLeslie RozeboomRafal DziadziuszkoPaul MitchellThomas JohnInigo S MillanShengxiang RenFred R HirschPublished in: Journal of surgical oncology (2022)
STING is ubiquitously expressed in NSCLC and associated with T cell function genes, AC histology, EGFR, and KRAS mutations and improved overall survival.